We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tools
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cvs Group Plc | LSE:CVSG | London | Ordinary Share | GB00B2863827 | ORD 0.2P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 17.00 | 1.12% | 1,532.00 | 18,747 | 14:15:02 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 1,531.00 | 1,536.00 | 1,544.00 | 1,505.00 | 1,526.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Veterinary Svcs-animal Specs | 608.3M | 41.9M | 0.5866 | 26.13 | 1.1B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 14:15:40 | O | 92 | 1,534.3475 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 30/11/2023 | 07:00 | UKREG | CVS Group plc Exercise of Options and Total Voting Rights |
| 29/11/2023 | 15:43 | UKREG | CVS Group plc Result of AGM |
| 29/11/2023 | 10:25 | ALNC |  CVS confident of further growth after making strong start to year |
| 29/11/2023 | 07:00 | UKREG | CVS Group plc AGM Statement and Trading Update |
| 24/11/2023 | 15:56 | UKREG | CVS Group plc Grant of Options under CVS Group plc |
| 03/11/2023 | 07:05 | UKREG | CVS Group plc Posting of Annual Report and Notice of AGM |
| 31/10/2023 | 16:46 | UKREG | CVS Group plc Exercise of Options and Total Voting Rights |
| 27/10/2023 | 09:06 | ALNC | IN BRIEF: CVS chair resigns due to ill health, finds interim successor |
| 27/10/2023 | 06:00 | UKREG | CVS Group plc Directorate Change |
| 13/10/2023 | 16:21 | UKREG | CVS Group plc Confirmation of dividend dates |
Cvs (CVSG) Share Charts1 Year Cvs Chart |
|
1 Month Cvs Chart |
Intraday Cvs Chart |
| Smart Money! CVSG is a large holding in the following funds: | ||
| Fund | Percentage of Fund | Last Updated |
| BLACKROCK THROGMORTON TRUST PLC | 2.60% | 2022-03-31 |
| BLACKROCK SMALLER COMPANIES TRUST PLC | 2.80% | 2022-12-31 |
| Date | Time | Title | Posts |
|---|---|---|---|
| 06/12/2023 | 08:48 | CVS Group: VETS,All things bright and beautiful | 830 |
| 07/10/2019 | 19:38 | Concerns founded? | 33 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 14:15:41 | 1,534.35 | 92 | 1,411.60 | O |
| 14:15:40 | 1,531.55 | 109 | 1,669.39 | O |
| 14:13:34 | 1,529.77 | 3 | 45.89 | O |
| 14:13:08 | 1,532.00 | 61 | 934.52 | AT |
| 14:13:08 | 1,532.00 | 62 | 949.84 | AT |
| Top Posts |
|---|
Posted at 07/12/2023 08:20 by Cvs Daily Update Cvs Group Plc is listed in the Veterinary Svcs-animal Specs sector of the London Stock Exchange with ticker CVSG. The last closing price for Cvs was 1,515p.Cvs currently has 71,429,755 shares in issue. The market capitalisation of Cvs is £1,095,018,144. Cvs has a price to earnings ratio (PE ratio) of 26.13. This morning CVSG shares opened at 1,526p |
Posted at 30/11/2023 16:12 by travis2 Agreed. I have been a long term observer of CVSG. They not only own a large number of Vet practices but the killer blow is that they also own one of the biggest online vet medicine outlets. Hence they profit twice, when selling to the practices as well as to the general public who have paid the vet for their animal's prescription. It's a win win for them. The regulator will make some token changes to make it look like they have done their job, but ultimately this business is solid and profitability will only increase in the long term. |
Posted at 09/11/2023 13:23 by 1jat Partly depends on what they find…..if they find higher prices where the company has local monopolies then possibly fines.More likely to agree remedies such as disposals, limits on concentration of practice ownership (bit like supermarkets) Also more paperwork and price disclosures telling people they can shop around. (But if your animal has a prescription you want it filled asap so I am not sure that saving a few pounds and waiting a few days for a postal delivery really helps). |
Posted at 01/10/2023 12:17 by waldron se811 Oct '23 - 09:49 - 806 of 806 0 0 0 Tipped in The Times “The shares are trading at a forward price/earnings multiple of under 16 for 2023 — lower than historic averages and also throwing open the prospect of an opportunistic private equity bid.” |
Posted at 01/10/2023 08:49 by se81 hxxps://www.thetimesTipped in The Times “The shares are trading at a forward price/earnings multiple of under 16 for 2023 — lower than historic averages and also throwing open the prospect of an opportunistic private equity bid.” |
Posted at 21/9/2023 12:43 by kalai1 CVS Group posted impressive Final Results for the year 30th June this morning. Revenue was up 9.8% to £608.3m, operating profit was up 45.6% to £62.3m, basic EPS was up 62.4% to £58.8m. Adjusted numbers were less stellar but still solid with adjusted EBITDA up 13% to £121.4m, adjusted EPS up 11.9% to 96p. The balance sheet remains solid despite the fact that Leverage increased to 0.73x as a result of the acquisition of Quality Pet Care Ltd. Net debt was up to £74m. Valuation is starting to look quite attractive with forward PE ratio at 15.9x, which is comfortably below the 23.6x trailing 12-month low for the share since FY17. The share price lacks positive momentum following its early September collapse following the Competition and Markets Authority launch of a review into the UK veterinary services market for household pets. CVSG remains a share to monitor for the time being, but company specific factors point to an increasingly attractive investment case......from WealthOracle |
Posted at 21/9/2023 07:03 by ariane CVS Group Reports Higher FY23 Profit, RevenueSeptember 21, 2023 at 02:35 am EDT (MT Newswires) -- CVS Group (CVSG.L) on Thursday reported year-over-year growth in profit and revenue for fiscal 2023. Profit for the year ended June 30 was 41.9 million pounds sterling, compared with 25.7 million pounds a year ago. EPS was 0.585 pound, compared with 0.359 pound. The UK veterinary group's revenue was 608.3 million pounds, compared with 554.2 million pounds previously. Analysts polled by Visible Alpha were expecting 65.4 million pounds in net income or 0.91 pound per share, while revenue was estimated at 605.8 million pounds. Meanwhile, the board proposed a final dividend of 0.075 pound per share for the period, payable on Dec. 8. It paid 0.070 pound per share a year ago. The stock rose nearly 1% in on Wednesday's close. Price (GBP): £1509.00, Change: £+13.00, Percent Change: +0.87% |
Posted at 14/9/2023 15:22 by adrian j boris RBC Upgrades CVS Group to Outperform from Sector Perform, Lowers PTSeptember 13, 2023 at 07:55 am EDT (MT Newswires) -- RBC on Wednesday upgraded its recommendation on CVS Group (CVSG.L) to outperform from sector perform and reduced its price target to 19.00 pounds sterling from 22.00 pounds. |
Posted at 07/9/2023 12:21 by babbler People will forget the news by the end of September. 2024 is a while away. CMA won't really do much anyway. They let Asda takeover through without flinching. That led to fuel price competition going. They will look at prices and probably blame inflation and staff costs and say not a lot can be done. If anything else is to go by it will just lead to prices rising. |
Posted at 07/9/2023 10:40 by maywillow Michele MaatoukSharecast News 07 Sep, 2023 09:35 07 Sep, 2023 09:41 Pets at Home, CVS tumble as CMA launches review of vet services Shares of Pets at Home and CVS Group tumbled on Thursday after the Competition and Markets Authority said it was launching a probe into the £2bn veterinary services market for household pets. The competition watchdog said it will explore how well the market is working for pet owners and whether they are receiving the information they need at the right time to get appropriate treatment for their pets. The CMA said it was keen to hear more about pet owners’ and vet practitioners’ experiences of pricing of services, including whether pet owners were aware of how much a treatment would cost, and how they pay for it. It also wants to hear about how prescriptions and medication for pets are arranged and sold and how pet owners choose a vet surgery - whether they are aware that their vet may be part of a larger chain which might also own other surgeries in the area. The use of out-of-hours and emergency vet services where options might be limited will also be looked into. CMA chief executive Sarah Cardell said: "Caring for an ill pet can create real financial pressure, particularly alongside other cost of living concerns. It’s really important that people get clear information and pricing to help them make the right choices. "There has been a lot of consolidation in the vet industry in recent years, so now is the right time to take a look at how the market is working. "When a pet is unwell, they often need urgent treatment, which means that pet owners may not shop around for the best deal, like they do with other services. This means they may not have the relevant information to make informed decisions at what can be a distressing time. We want to hear from pet owners and people who work in the sector about their experiences." Pets at Home owns veterinary groups Companion Care Vets and Vets4Pets and has a network of more than 450 vet practices across the UK. CVS Group, meanwhile, is one of the largest integrated veterinary services providers in the UK. At 0925 BST, Pets shares were down 11.2% at 336.20p. Shares of AIM-listed vet services provider CVS Group were down 29% at 1,479.00p. Russ Mould, investment director at AJ Bell, said: "Being in the pets and vet space has felt like a healthy place to be in recent years. That’s been reflected in strong share prices for the likes of vet group CVS and Pets at Home which has its own veterinary arm within a broader retail and grooming offering. "Britons love their animal companions and are willing to pay up to keep them healthy and happy. "News that the competition authorities are looking into the rising costs and potentially anti-competitive practices in the industry has set the cat among the pigeons when it comes to the share prices of CVS and Pets at Home. "The sell-off seen today could be an overreaction, although the CMA review looks to be wide-ranging. The problem for both businesses is the process is likely to be time-consuming and, with a further update not due until early 2024, it could weigh on both stocks for some time to come." |
Posted at 07/9/2023 07:36 by 74tom "People may also be unaware if their vet is part of a group which owns other vet practices in their area or that the services which are being sold to them (such as diagnostic tests or treatments at a specialist animal hospital) are provided by that group. This could impact pet owners’ choices and reduce the incentives of local vet practices to compete."I'm not sure what measures the CMA could impose to remedy the situation, however it doesn't surprise me that the listed vet group's are being targeted. From a quick check I can see that CVSG reported a gross margin of 77% last year, in fairness this hasn't changed much over the last 5 years, but the scale of the business has grown. At the end of 2022 they owned 472 of the estimated 5300 UK vet practices & 85.5% of revenue was derived from them. In 2015 they owned 298, so market share has nearly doubled. The main takeaway is that CVSG's future growth runway via acquisitions now looks shrouded in uncertainty & their top line revenues could well come under pressure. Certainly a very aggressive move down though... |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
